U.S. Infrastructure Stock News

Warner Music Group Corp. recently reported past third-quarter 2026 results showing sales of US$1,864 million and net income of US$204 million, reaffirmed fiscal 2026 guidance for high single-digit revenue growth, and declared a regular quarterly cash dividend of US$0.20 per share payable on September 1, 2026. Together, the strong year-over-year improvement in profitability, consistent revenue outlook, and continued cash returns via dividends highlight Warner Music Group’s focus on balancing...

UFP Technologies, Inc. reported past second-quarter 2026 results with sales of US$173.96 million and net income of US$20.85 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. For the first half of 2026, the company showed higher sales and net income than the prior year period, pointing to improved profitability and operating performance across its core business. With stronger year-on-year sales and earnings in both the quarter and...

ConnectOne Bancorp (CNOB) stock is in focus after recent trading data showed mixed short term moves and a stronger longer term record, which gives investors fresh context for assessing this regional bank. See our latest analysis for ConnectOne Bancorp. With the share price at about US$33.03, ConnectOne Bancorp has seen mixed short term trading. The 90 day share price return of 13.64% sits alongside a 26.44% year to date share price return and a 40.83% 1 year total shareholder return, which...

NANO Nuclear Energy Inc. recently reported third-quarter 2026 results, posting US$214,042 in sales and a US$10.1 million net loss, and has since held its Q3 earnings call and presented at Citi’s 2026 Natural Resources Conference in Las Vegas and Needham’s 15th Annual Virtual Industrial Tech, Robotics & Power 1x1 Conference. While the company remains loss making, the nine‑month net loss narrowed to US$25.8 million with basic loss per share holding at US$0.19 for the quarter and improving to...

Restructuring playbooks that once sat inside private equity funds are now turning up in listed MedTech groups, with job cuts, asset sales and portfolio reviews all hitting the headlines at the same time as regulatory setbacks and fresh takeover interest. That mix can create sharp winners and quiet laggards. This article walks through three MedTech stocks exposed to these catalysts and explains how investors might think about the risks and potential rewards. The stocks covered in this article...

Novavax (NVAX) is back in focus after its latest quarterly report showed revenue of US$56.7 million and a swing from profit to a net loss, along with a new US$82.5 million shelf registration filing. See our latest analysis for Novavax. The latest results and shelf registration have landed against a mixed backdrop for Novavax, with the 1-day share price return down 1.11% but the year-to-date share price return up 12.90%, while the 1-year total shareholder return has declined 17.10%. If you are...

Bank of Hawaii (BOH) has drawn investor focus after recent trading left the stock at US$80.29. The move comes alongside mixed short term returns, with a gain over the past 3 months but a decline over the past month. See our latest analysis for Bank of Hawaii. Set against a 1-day share price return of 0.54% and a 7-day share price return of 2.03%, Bank of Hawaii’s 30-day share price return of 6.48% is weaker compared with its 17.35% year to date share price return and 28.70% 1-year total...

In August 2026, Mattel reported its second-quarter and six-month results, with quarterly sales rising to US$1,125.3 million while the period swung to a net loss compared with income a year earlier. Over the same timeframe, Mattel disclosed it had completed repurchasing 18,353,965 shares for US$298.31 million under its February 2026 buyback program, reducing its share count meaningfully. We’ll now examine how Mattel’s shift to a quarterly loss alongside its sizeable buyback completion shapes...

Permian Basin Royalty Trust (PBT) recently reported second quarter and first half 2026 results, with higher revenue and net income than a year earlier, drawing fresh attention from income focused energy investors. See our latest analysis for Permian Basin Royalty Trust. At a share price of US$32.69, Permian Basin Royalty Trust has seen strong momentum, with an 85.84% year to date share price return and a very large 5 year total shareholder return of 652.56%. The 1 year total shareholder...

Vir Biotechnology, Inc. reported second-quarter 2026 results showing revenue of US$238.95 million versus US$1.21 million a year earlier, with net income of US$80.08 million replacing a net loss of US$110.96 million and earnings per share from continuing operations turning to US$0.48 basic and US$0.47 diluted. Over the first half of 2026, revenue rose to US$238.92 million from US$4.25 million, while the company reduced its net loss to US$45.62 million and sharply improved loss per share,...

Powell Industries earnings and acquisition plans set the stage Powell Industries (POWL) has drawn fresh attention after reporting third quarter and year to date results, along with comments about an active acquisition pipeline focused on expanding services and complementary products. See our latest analysis for Powell Industries. At a share price of US$213.48, Powell Industries has experienced short term share price pressure over the past month and quarter. However, its year to date share...

American States Water Company reported past second-quarter 2026 results showing sales and revenue of US$181.29 million and net income of US$43.27 million, all higher than a year earlier, with diluted EPS from continuing operations at US$1.09 versus US$0.87. These results also lifted performance for the first half of 2026, with revenue up to US$350.48 million and net income at US$73.22 million, underscoring improving profitability across the period. With this step-up in quarterly earnings now...

Recent performance snapshot for Cracker Barrel Old Country Store Cracker Barrel Old Country Store (CBRL) has drawn fresh investor attention after a sharp share price move over the past 3 months, with the stock also showing a strong year to date gain. Over the past month the stock is up about 8%, while the past 3 months show a very large positive return. Year to date the move is also strong, contrasting with a modest decline over the past year. See our latest analysis for Cracker Barrel Old...

OneMain Holdings (OMF) recently completed two senior unsecured fixed income offerings totaling US$1.1b in notes due 2034, including 7.125% notes, a funding move that reshapes its debt profile and long term interest obligations. See our latest analysis for OneMain Holdings. Against this refinancing backdrop, OneMain Holdings’ recent share price momentum has been positive, with a 30 day share price return of 8.92% and a 90 day return of 24.16%, while the year to date share price return has...

Sterling Infrastructure (STRL) is back in focus after strong second quarter results and a higher 2026 earnings outlook, as management pointed to robust sales, net income and a growing project backlog. See our latest analysis for Sterling Infrastructure. The earnings guidance upgrade has arrived alongside a sharp move in Sterling Infrastructure’s share price, with a 1-day share price return of 4.22% and a 7-day share price return of 9.08% following recent results and acquisition commentary...

On 13 August 2026, OPKO Health expanded its financing relationship with HealthCare Royalty, issuing US$125,000,000 of senior secured notes maturing in 2044 and backed by royalty interests from its mazdutide license with Eli Lilly, converting future royalties into immediate non-dilutive capital. A key feature of this structure is the 1.5-times cap on total payments funded by mazdutide-related royalties, after which OPKO retains full future royalty economics from the financed stream, balancing...

In August 2026, Definium Therapeutics reported that its Phase 3 Voyage trial of DT120 ODT in generalized anxiety disorder met the primary and all key secondary endpoints, delivering statistically significant reductions in HAM-A anxiety scores versus placebo with generally mild to moderate, transient side effects and no new safety signals. The results also showed rapid symptom improvement as early as Day 2, along with meaningful differences in response and remission rates, underscoring how a...

Wingstop (WING) has been back on investors’ radar after government data showed wholesale food costs easing, which could support restaurant margins as the company pushes fresh promotions and returning flavors. See our latest analysis for Wingstop. Wingstop’s 10.73% 1 day share price gain to US$126.12 followed the easing food cost data and fresh promotions, although the 30 day share price return is down 11.39% and the 1 year total shareholder return is down 62.57%. This points to momentum still...

Brookfield Wealth Solutions (BNT) has drawn fresh attention after its second quarter update showed revenue of US$4.22b with net income of US$143m, alongside an affirmed quarterly return of capital of US$0.07 per share. See our latest analysis for Brookfield Wealth Solutions. The earnings update and affirmed return of capital have come as Brookfield Wealth Solutions’ share price has eased in the short term, with a year to date share price return showing a 6.11% decline but a three year total...

The digital payment sector continues to evolve rapidly, as demonstrated by Yuno's recent successful completion of a $45 million Series B funding round. Led by Global PayTech Ventures, this investment reflects the growing demand for advanced global payment systems and financial services infrastructure. With plans to enhance its AI-native platform, Yuno aims to bolster its global payments network, which supports a wide range of financial services and payment methods across 190 countries. This...

Royal Caribbean Cruises (RCL) recently raised about US$1.25b through a new fixed income offering of callable, senior unsecured notes due 2034, a move that puts its capital structure in sharper focus for stock investors. See our latest analysis for Royal Caribbean Cruises. The 1-day share price return for Royal Caribbean Cruises declined 1.57%. The 30-day and 90-day share price returns of 6.29% and 23.38% suggest momentum has been building despite a 1-year total shareholder return that is down...

Guidewire Software (GWRE) recently launched its Qusar release featuring a new Agentic Framework that lets insurers build and manage AI agents across policy, claims, billing, and development workflows on Guidewire Cloud Platform. See our latest analysis for Guidewire Software. Guidewire Software's recent Qusar release with its Agentic Framework comes as the stock shows strong recent momentum, with a 30 day share price return of 17.04% and a 90 day share price return of 25.41%. This is despite...

Capricor Therapeutics (CAPR) is back in focus after reporting second quarter 2026 results and wider losses, alongside ongoing legal and regulatory questions around its lead Duchenne muscular dystrophy candidate, Deramiocel. See our latest analysis for Capricor Therapeutics. The latest Q2 loss and ongoing Deramiocel scrutiny have come alongside sharp volatility in Capricor Therapeutics’ stock, with the share price jumping 58% in the last day and 73% over seven days, yet still down strongly...

J. M. Smucker stock has delivered a solid 25.6% year to date return, yet the company currently screens as overvalued on market multiples and scores poorly on broader valuation checks. For investors, that raises the question of whether the recent share price strength has already priced in much of the good news. J. M. Smucker is up 25.6% year to date, which points to a strong rebound in sentiment after a mixed few years of returns. Future pricing power and brand strength can support the...